Forte Biosciences, Inc.
General ticker "FBRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $125.9M (TTM average)
Forte Biosciences, Inc. follows the US Stock Market performance with the rate: 26.0%.
Estimated limits based on current volatility of 7.0%: low 17.01$, high 19.58$
Factors to consider:
- Total employees count: 67 as of 2017
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.41$, 30.56$]
- 2025-12-31 to 2026-12-31 estimated range: [3.25$, 14.84$]
Financial Metrics affecting the FBRX estimates:
- Negative: with PPE of -1.2 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -51.65 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of -16.34 <= 0
- Negative: negative Industry operating income (median)
Short-term FBRX quotes
Long-term FBRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $13.90MM | $32.49MM | $36.60MM |
| Operating Income | $-13.90MM | $-32.49MM | $-36.60MM |
| Non-Operating Income | $0.02MM | $1.01MM | $1.12MM |
| R&D Expense | $5.59MM | $21.86MM | $21.19MM |
| Income(Loss) | $-13.88MM | $-31.48MM | $-35.48MM |
| Profit(Loss)* | $-13.86MM | $-31.48MM | $-35.48MM |
| Stockholders Equity | $38.82MM | $35.31MM | $52.48MM |
| Assets | $42.00MM | $38.98MM | $61.56MM |
| Operating Cash Flow | $-8.19MM | $-28.71MM | $-30.75MM |
| Capital expenditure | $0.00MM | $0.09MM | $0.04MM |
| Investing Cash Flow | $0.00MM | $0.05MM | $-35.99MM |
| Financing Cash Flow | $7.24MM | $24.68MM | $51.86MM |
| Earnings Per Share** | $-19.94 | $-24.92 | $-12.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.